Noroxymorphone is a strategic, semi-synthetic opioid intermediate manufactured by Parand Darou Co. This compound serves as a critical precursor and the fundamental building block in the synthesis of life-saving opioid antagonists, including Naloxone and Naltrexone, as well as the potent analgesic derivative Nalbuphine.
Pharmacological Significance
Characterized by a hydroxyl group at the C-14 position and a dihydromorphinan backbone, Noroxymorphone is a pivotal substrate in chemical alkylation processes. Access to this high-purity intermediate is essential for ensuring the clinical efficacy of emergency medications utilized in the management of opioid toxicity and acute overdose conditions.
Quality Assurance & Storage
At Parand Darou Co., Noroxymorphone is produced under strict Quality Control (QC) protocols, adhering to stringent In-house Specifications with a minimum chemical purity of 99.0%. To maintain its physicochemical integrity, the compound must be stored in tightly sealed, light-protected containers. It is guaranteed to be stable for at least 2 years when stored at room temperature.
General Information
| Product Name | Noroxymorphone | |
| Chemical Name | 7,8-Dihydro-14-hydroxynormorphinone | |
| Manufacturer | Parand Darou Co. | |
| CAS No. | 33522-95-1 | |
| Pharmacopoeia | In-house |
Specification
| Molecular formula | C16H17NO4 | Purity | Min 99.0% | |||
| Molecular weight | 287.32 | Assay | 98.0% to 101.0% | |||
| Appearance | Creamy to off-white powder | Storage | Well closed, light protected | |||
| Water | Max 3.0% | Stability | 2 years at RT | |||
| Residue on ignition | Max 0.1% |
